Fresenius Medical Care uses cookies on this website to enhance the user experience and provide the best possible service. By continuing to browse the website, you consent to our use of cookies. For details see our privacy policy.
Fresenius Medical Care Ventures was established to invest in start-ups and early-stage companies in the healthcare sector. The investments are targeted to support Fresenius Medical Care’s corporate strategy to grow continuously in our core business and to expand into new business areas. Fresenius Medical Care Ventures is complementing the corporate activities in external innovation.
Mission
Portfolio
Team
News
Contact Us
Our Mission
Fresenius Medical Care Ventures invests in early stage companies that develop products, technologies and therapies which will have a significant value for the patient and for the healthcare system.
Sectors of Interest
Products and technologies of interest include medical devices, patient monitoring, eHealth solutions, regenerative medicine and pharmaceuticals which provide innovative and potentially transformative approaches in the following therapeutic sectors:
Chronic Kidney Disease and Dialysis
Intensive Care Medicine
Cardiovascular Disease
Diabetes
Extracorporeal Therapies
Our Portfolio
Fresenius Medical Care Ventures has been launched only recently and is in the process of establishing an active portfolio.
ExThera
ExThera Medical is developing revolutionary medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking.
Modulated Imaging is developing and marketing devices for determining oxygenation levels in superficial tissues for patients with potential circulatory compromise.
John Viero Regional Director Product and Marketing Innovation LinkedIn profile
News
Upcoming Conferences
Fresenius Medical Care Ventures will attend the following partnering conferences
J.P. Morgan 36th Annual Healthcare Conference, January 8-11, 2018, San Francisco, USA
Modulated Imaging Completes Series A Funding
Irvine, CA – November 15, 2017 – Modulated Imaging, Inc., announced today that it has closed a $2.86 million Series A financing round to support growing market interest and demand for its innovative light-based imaging technology. This represents the medical device company’s second financing round since July of last year. The round was led by Grey Sky Venture Partners. Also participating was Mitsubishi UFJ Capital Co, Ltd, Fresenius Medical Care Ventures GmbH and, making a second investment in the company, Hamamatsu Photonics K.K. through its wholly-owned subsidiary Photonics Management Corporation.
ExThera Medical Closes Financing Led by Fresenius Medical Care Ventures to Support Commercialization of Innovative Technology to Remove Pathogens from Whole Blood
Martinez, Calif. – June 2, 2016 – ExThera Medical Corporation, the leading developer of innovative blood filtering technology to address major global health problems, today announced that the company has closed a Series B financing round with an equity investment led by new investor Fresenius Medical Care Ventures GmbH. The round included existing investors, and the conversion of the company’s convertible note, for a total of $15.3 million. Other terms were not disclosed.
